D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 115 SEK
Market Cap: 1.9B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Wall Street
Price Targets

DVYSR Price Targets Summary
Devyser Diagnostics AB

Wall Street analysts forecast DVYSR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVYSR is 146.63 SEK with a low forecast of 101 SEK and a high forecast of 201.6 SEK.

Lowest
Price Target
101 SEK
12% Downside
Average
Price Target
146.63 SEK
28% Upside
Highest
Price Target
201.6 SEK
75% Upside
Devyser Diagnostics AB Competitors:
Price Targets
6955
Shandong Boan Biotechnology Co Ltd
31% Upside
INSM
Insmed Inc
29% Upside
ABBV
Abbvie Inc
20% Upside
4882
Perseus Proteomics Inc
38% Upside
ADAG
Adagene Inc
350% Upside
4891
TMS Co Ltd
254% Upside
ACHV
Achieve Life Sciences Inc
342% Upside
GNS
Genus PLC
60% Upside

Revenue
Forecast

Revenue Estimate
Devyser Diagnostics AB

For the last 4 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 27%. The projected CAGR for the next 3 years is 38%.

27%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
42%
Average Beat

Net Income
Forecast

Net Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DVYSR's stock price target?
Price Target
146.63 SEK

According to Wall Street analysts, the average 1-year price target for DVYSR is 146.63 SEK with a low forecast of 101 SEK and a high forecast of 201.6 SEK.

What is Devyser Diagnostics AB's Revenue forecast?
Projected CAGR
38%

For the last 4 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 27%. The projected CAGR for the next 3 years is 38%.

Back to Top